Ethosuximide Capsule
Product Images NDC 64380-878

2 FDA label images from Strides Pharma Science Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ethosuximide (NDC 64380-878). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Structure (6f135052 6c5c 4aa1 9449 Aab2d197627b 01)

Molecular Structure (6f135052 6c5c 4aa1 9449 Aab2d197627b 01)
Chemical structure of ethosuximide, showing its molecular framework including a succinimide ring with attached ethyl and methyl groups.*
FDA Label Image

100s-container-label (100s Container Label)

100s-container-label (100s Container Label)
Label for Ethosuximide Capsules USP 250 mg, oral capsules supplied by Strides Pharma Science Limited. The label indicates storage conditions, prescribing guidance, and includes barcode, NDC 64380-878-06, and package size of 100 capsules. It directs pharmacists to dispense a medication guide with the capsules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.